{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:21:39Z","timestamp":1789924899302,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J ECT"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This randomized controlled pilot study examines the differences in response to electroconvulsive therapy (ECT) as defined by an improvement of depressive symptoms between ketamine and methohexital as the primary anesthetic agent. Adverse effects and cognitive tolerability were also examined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Subjects undergoing ECT for unipolar or bipolar depression were randomized to receive ketamine or methohexital as the anesthetic agent. Primary outcome measure includes the Hamilton rating scale for depression (17-item). Secondary outcome measures included the mini-mental status examination and Beck depression inventory. All ratings were conducted masked to anesthetic agent. Because of multiple outcome measures obtained over time, mixed models were used to account for the correlations among the measurements within the subjects. Because outcomes were either normally distributed or approximately normally distributed, general linear mixed models were fit with a random intercept specified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 21 subjects were enrolled, and 16 were randomized (methohexital, n = 8; ketamine, n = 8). The 2 treatment groups did not differ statistically in any demographic characteristic. No statistical difference was found between the ketamine and methohexital groups for an improvement in depressive symptoms (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.6); however, subjects in both groups showed significant improvement in depression over time (ketamine, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001; methohexital, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). Mini-mental status examination results did not differ between groups, and fatigue was reported more in subjects receiving ketamine (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The results of this pilot study are inconclusive because they lack power to support an advantage of ketamine anesthesia compared with methohexital in ameliorating depressive symptoms for electroconvulsive therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/yct.0000000000000413","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T13:33:16Z","timestamp":1492608796000},"page":"268-271","source":"Crossref","is-referenced-by-count":29,"title":["A Randomized Pilot Study Comparing Ketamine and Methohexital Anesthesia for Electroconvulsive Therapy in Patients With Depression"],"prefix":"10.1097","volume":"33","author":[{"given":"Shona L.","family":"Ray-Griffith","sequence":"first","affiliation":[{"name":"From the Departments of *Psychiatry, \u2020Obstetrics and Gynecology, and \u2021Anesthesia, University of Arkansas for Medical Sciences, Little Rock, AR; and \u00a7Department of Pediatrics, Arkansas Children's Hospital, Little Rock, AR."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou Ann","family":"Eads","sequence":"additional","affiliation":[{"name":"From the Departments of *Psychiatry, \u2020Obstetrics and Gynecology, and \u2021Anesthesia, University of Arkansas for Medical Sciences, Little Rock, AR; and \u00a7Department of Pediatrics, Arkansas Children's Hospital, Little Rock, AR."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Han","sequence":"additional","affiliation":[{"name":"From the Departments of *Psychiatry, \u2020Obstetrics and Gynecology, and \u2021Anesthesia, University of Arkansas for Medical Sciences, Little Rock, AR; and \u00a7Department of Pediatrics, Arkansas Children's Hospital, Little Rock, AR."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Golden","sequence":"additional","affiliation":[{"name":"From the Departments of *Psychiatry, \u2020Obstetrics and Gynecology, and \u2021Anesthesia, University of Arkansas for Medical Sciences, Little Rock, AR; and \u00a7Department of Pediatrics, Arkansas Children's Hospital, Little Rock, AR."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary N.","family":"Stowe","sequence":"additional","affiliation":[{"name":"From the Departments of *Psychiatry, \u2020Obstetrics and Gynecology, and \u2021Anesthesia, University of Arkansas for Medical Sciences, Little Rock, AR; and \u00a7Department of Pediatrics, Arkansas Children's Hospital, Little Rock, AR."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231021","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"bib2-20231021","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/bjaceaccp\/mkq039","article-title":"Anaesthesia for electroconvulsive therapy","volume":"10","year":"2010","journal-title":"Continuing Education in Anaesthesia, Critical Care & Pain"},{"key":"bib3-20231021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1176\/jnp.15.1.27","article-title":"Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT","volume":"15","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"bib4-20231021","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00406-011-0205-7","article-title":"Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study","volume":"261","year":"2011","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"bib5-20231021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/YCT.0b013e3182a4b4c6","article-title":"Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study","volume":"30","year":"2014","journal-title":"J ECT"},{"key":"bib6-20231021","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/YCT.0b013e3181c3b0aa","article-title":"Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia","volume":"26","year":"2010","journal-title":"J ECT"},{"key":"bib7-20231021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/YCT.0b013e31824d1d02","article-title":"Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder","volume":"28","year":"2012","journal-title":"J ECT"},{"key":"bib8-20231021","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.psychres.2013.12.027","article-title":"A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy","volume":"215","year":"2014","journal-title":"Psychiatry Res"},{"key":"bib9-20231021","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/YCT.0b013e31824f8296","article-title":"Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting","volume":"28","year":"2012","journal-title":"J ECT"},{"key":"bib10-20231021","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/YCT.0b013e318283b7e9","article-title":"Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study","volume":"29","year":"2013","journal-title":"J ECT"},{"key":"bib11-20231021","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","year":"2015","journal-title":"Am J Psychiatry"},{"key":"bib12-20231021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00124509-200606000-00005","article-title":"Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies","volume":"22","year":"2006","journal-title":"J ECT"},{"key":"bib13-20231021","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","year":"2000","journal-title":"Biol Psychiatry"},{"key":"bib14-20231021","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","year":"2013","journal-title":"Am J Psychiatry"},{"key":"bib15-20231021","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","year":"2009","journal-title":"Biol Psychiatry"},{"key":"bib16-20231021","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","year":"2013","journal-title":"Biol Psychiatry"},{"key":"bib17-20231021","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","year":"2010","journal-title":"Biol Psychiatry"},{"key":"bib19-20231021","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib20-20231021","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"bib21-20231021","first-page":"189","article-title":"\u201cMini-mental state\u201d a practical method for grading the cognitive state of patients for the clinician","volume":"12","year":"1975","journal-title":"J Psychiatr Res"}],"container-title":["The Journal of ECT"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00124509-201712000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T08:45:23Z","timestamp":1697877923000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124509-201712000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/yct.0000000000000413","relation":{},"ISSN":["1533-4112","1095-0680"],"issn-type":[{"value":"1533-4112","type":"electronic"},{"value":"1095-0680","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}